Related references
Note: Only part of the references are listed.Serum and tissue biomarkers as predictive and prognostic variables in epithelial ovarian cancer
Angiolo Gadducci et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2009)
Functional Roles of Human Kallikrein-related Peptidases
Georgia Sotiropoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Beyond chemotherapy: targeted therapies in ovarian cancer
Timothy A. Yap et al.
NATURE REVIEWS CANCER (2009)
The early detection of ovarian cancer: from traditional methods to proteomics. Can we really do better than serum CA-125?
Vladimir Nossov et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2008)
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7
Mekdes Debela et al.
BIOLOGICAL CHEMISTRY (2008)
Prediction of ovarian cancer prognosis and response to chemotherapy by a serum-based multiparametric biomarker panel
K. Oikonomopoulou et al.
BRITISH JOURNAL OF CANCER (2008)
Advances in Breast Cancer: Pathways to Personalized Medicine
Olufunmilayo I. Olopade et al.
CLINICAL CANCER RESEARCH (2008)
Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers
Nashmil Emami et al.
CLINICAL CHEMISTRY (2008)
Cancer antigen 125 and prognosis
Estrid Hogdall
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2008)
Discovery and application of protein biomarkers for ovarian cancer
Audrey Gagnon et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2008)
Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions
Andrea Jurisicova et al.
EXPERT REVIEW OF PROTEOMICS (2008)
A multiparametric panel for ovarian cancer diagnosis, prognosis, and response to chemotherapy
Yingye Zheng et al.
CLINICAL CANCER RESEARCH (2007)
Structural basis of the zinc inhibition of human tissue kallikrein 5
Mekdes Debela et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Distribution of 15 human kallikreins in tissues and biological fluids
Julie L. V. Shaw et al.
CLINICAL CHEMISTRY (2007)
Ovarian cancer
Nicoletta Colombo et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2006)
Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma
Julia Dorn et al.
BIOLOGICAL CHEMISTRY (2006)
Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells
Panagiotis Prezas et al.
BIOLOGICAL CHEMISTRY (2006)
Molecular prognostic markers in ovarian cancer: toward patient-tailored therapy
APG Crijns et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Potential markers that complement expression of CA125 in epithelial ovarian cancer
DG Rosen et al.
GYNECOLOGIC ONCOLOGY (2005)
New tumor markers: CA125 and beyond
RC Bast et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2005)
Human tissue kallikrein gene family: applications in cancer
CV Obiezu et al.
CANCER LETTERS (2005)
Cancer of the ovary
SA Cannistra
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
Immunofluorometric quantification of human kallikrein 5 expression in ovarian cancer cytosols and its association with unfavorable patient prognosis
EP Diamandis et al.
TUMOR BIOLOGY (2003)
Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
H Kim et al.
BRITISH JOURNAL OF CANCER (2001)
Share Paper
